Summary
Residual Barrier Technology Ltd. is an SME set up with the aim of developing disruptive, green sanitation products while delivering higher performance than state of the art solutions and thus achieve impact globally.
Disinfectants are relied on as the last line of defense against ever-evolving bacteria and viruses – but due to current chemistry they come with inherent disadvantages including, toxic/mutagenic ingredient use and offers no residual protection.
Methods application such as spraying, fogging and fumigation are time and labour intensive and provide inconsistent and incomplete coverage.
We have developed VIRIDIS a patent pending non-toxic, non-mutagenic platform disinfectant that is a breakthrough in the fight to effectively eradicate bacterial pathogens, spoilage organisms, and viruses. However, VIRIDIS MIST does not stop there – once deposited on a surface the advanced micelles holding the active ingredients crystallise to create a protective residual barrier that has been independently proven to continue to kill bacteria for days even when dry - preventing them from rebuilding or mutating to form a resistance.
We currently work with clients in the food processing and agriculture market to design and fit bespoke large scale residual misting systems for their facilities operating on a service charge model. However, there is a considerable expense and time involved in installing the network of fixed pipes and nozzles at their sites – making it cost prohibitive in small to medium sites and impossible to implement in haulage and shipping contexts. VIRIDIS MIST will service this much larger market micromedium scale market through the use of autonomous mobile apparatus. We are requesting funding for the development and production of 24 demonstrator application (8 x 3 different sizes) systems to gain customer confidence among our suppliers and end users.
Disinfectants are relied on as the last line of defense against ever-evolving bacteria and viruses – but due to current chemistry they come with inherent disadvantages including, toxic/mutagenic ingredient use and offers no residual protection.
Methods application such as spraying, fogging and fumigation are time and labour intensive and provide inconsistent and incomplete coverage.
We have developed VIRIDIS a patent pending non-toxic, non-mutagenic platform disinfectant that is a breakthrough in the fight to effectively eradicate bacterial pathogens, spoilage organisms, and viruses. However, VIRIDIS MIST does not stop there – once deposited on a surface the advanced micelles holding the active ingredients crystallise to create a protective residual barrier that has been independently proven to continue to kill bacteria for days even when dry - preventing them from rebuilding or mutating to form a resistance.
We currently work with clients in the food processing and agriculture market to design and fit bespoke large scale residual misting systems for their facilities operating on a service charge model. However, there is a considerable expense and time involved in installing the network of fixed pipes and nozzles at their sites – making it cost prohibitive in small to medium sites and impossible to implement in haulage and shipping contexts. VIRIDIS MIST will service this much larger market micromedium scale market through the use of autonomous mobile apparatus. We are requesting funding for the development and production of 24 demonstrator application (8 x 3 different sizes) systems to gain customer confidence among our suppliers and end users.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/774582 |
| Start date: | 01-07-2017 |
| End date: | 31-10-2017 |
| Total budget - Public funding: | 71 429,00 Euro - 50 000,00 Euro |
Cordis data
Original description
Residual Barrier Technology Ltd. is an SME set up with the aim of developing disruptive, green sanitation products whiledelivering higher performance than state of the art solutions and thus achieve impact globally.
Disinfectants are relied on as the last line of defense against ever-evolving bacteria and viruses – but due to current
chemistry they come with inherent disadvantages including, toxic/mutagenic ingredient use and offers no residual protection.
Methods application such as spraying, fogging and fumigation are time and labour intensive and provide inconsistent and
incomplete coverage.
We have developed VIRIDIS a patent pending non-toxic, non-mutagenic platform disinfectant that is a breakthrough in the
fight to effectively eradicate bacterial pathogens, spoilage organisms, and viruses. However, VIRIDIS MIST does not stop
there – once deposited on a surface the advanced micelles holding the active ingredients crystallise to create a protective
residual barrier that has been independently proven to continue to kill bacteria for days even when dry - preventing them
from rebuilding or mutating to form a resistance.
We currently work with clients in the food processing and agriculture market to design and fit bespoke large scale residual
misting systems for their facilities operating on a service charge model. However, there is a considerable expense and time
involved in installing the network of fixed pipes and nozzles at their sites – making it cost prohibitive in small to medium sites
and impossible to implement in haulage and shipping contexts. VIRIDIS MIST will service this much larger market micromedium
scale market through the use of autonomous mobile apparatus. We are requesting funding for the development and
production of 24 demonstrator application (8 x 3 different sizes) systems to gain customer confidence among our suppliers
and end users.
Status
CLOSEDCall topic
SMEInst-07-2016-2017Update Date
27-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
H2020-EU.3.2. SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy
H2020-EU.3.2.4. Sustainable and competitive bio-based industries and supporting the development of a European bioeconomy
